{
    "address1": "2929 7th Street",
    "address2": "Suite 105",
    "city": "Berkeley",
    "state": "CA",
    "zip": "94710",
    "country": "United States",
    "phone": "510 982 6030",
    "website": "https://cariboubio.com",
    "industry": "Biotechnology",
    "sector": "Healthcare",
    "longBusinessSummary": "Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.",
    "fullTimeEmployees": 137,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Dr. Rachel E. Haurwitz Ph.D.",
            "age": 36,
            "title": "Co-Founder, CEO, Pres & Director",
            "yearBorn": 1986,
            "fiscalYear": 2022,
            "totalPay": 833468,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Ruhi A. Khan M.B.A.",
            "age": 47,
            "title": "Chief Bus. Officer",
            "yearBorn": 1975,
            "fiscalYear": 2022,
            "totalPay": 573900,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Syed Ali-aamir Rizvi M.D.",
            "age": 55,
            "title": "Chief Medical Officer",
            "yearBorn": 1967,
            "fiscalYear": 2022,
            "totalPay": 677076,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Jason V. O'Byrne M.B.A.",
            "age": 53,
            "title": "CFO & Principal Accounting Officer",
            "yearBorn": 1969,
            "fiscalYear": 2021,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Daniel  Poon",
            "title": "VP of Operations & Information Technology",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Justin  Skoble",
            "title": "VP of Technical Operations",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Steven B. Kanner Ph.D.",
            "age": 63,
            "title": "Chief Scientific Officer",
            "yearBorn": 1959,
            "fiscalYear": 2020,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Amy  Figueroa C.F.A.",
            "title": "VP of Investor Relations & Corp. Communications",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Barbara G. McClung Esq., J.D.",
            "age": 67,
            "title": "Chief Legal Officer & Corp. Sec.",
            "yearBorn": 1955,
            "fiscalYear": 2021,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Cindy  Hayashi",
            "title": "VP of HR",
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 2,
    "boardRisk": 5,
    "compensationRisk": 8,
    "shareHolderRightsRisk": 8,
    "overallRisk": 6,
    "governanceEpochDate": 1693526400,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 5.79,
    "open": 5.8,
    "dayLow": 5.68,
    "dayHigh": 5.889,
    "regularMarketPreviousClose": 5.79,
    "regularMarketOpen": 5.8,
    "regularMarketDayLow": 5.68,
    "regularMarketDayHigh": 5.889,
    "payoutRatio": 0.0,
    "beta": 1.978965,
    "forwardPE": -3.0967743,
    "volume": 1716240,
    "regularMarketVolume": 1716240,
    "averageVolume": 3376208,
    "averageVolume10days": 1715550,
    "averageDailyVolume10Day": 1715550,
    "bid": 0.0,
    "ask": 0.0,
    "bidSize": 1800,
    "askSize": 1100,
    "marketCap": 508520480,
    "fiftyTwoWeekLow": 3.96,
    "fiftyTwoWeekHigh": 13.19,
    "priceToSalesTrailing12Months": 35.68064,
    "fiftyDayAverage": 6.3836,
    "twoHundredDayAverage": 5.989925,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": 276522304,
    "profitMargins": 0.0,
    "floatShares": 71707544,
    "sharesOutstanding": 88284800,
    "sharesShort": 6842674,
    "sharesShortPriorMonth": 8197870,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.0775,
    "heldPercentInsiders": 0.13735,
    "heldPercentInstitutions": 0.59398997,
    "shortRatio": 3.63,
    "shortPercentOfFloat": 0.0813,
    "bookValue": 4.077,
    "priceToBook": 1.4128035,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "netIncomeToCommon": -111199000,
    "trailingEps": -1.73,
    "forwardEps": -1.86,
    "pegRatio": 0.33,
    "enterpriseToRevenue": 19.402,
    "enterpriseToEbitda": -2.325,
    "exchange": "NMS",
    "quoteType": "EQUITY",
    "symbol": "CRBU",
    "underlyingSymbol": "CRBU",
    "shortName": "Caribou Biosciences, Inc.",
    "longName": "Caribou Biosciences, Inc.",
    "firstTradeDateEpochUtc": 1627047000,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 5.76,
    "targetHighPrice": 30.0,
    "targetLowPrice": 19.0,
    "targetMeanPrice": 23.86,
    "targetMedianPrice": 23.0,
    "recommendationMean": 1.6,
    "recommendationKey": "buy",
    "numberOfAnalystOpinions": 7,
    "totalCash": 259232000,
    "totalCashPerShare": 2.936,
    "ebitda": -118937000,
    "totalDebt": 27234000,
    "quickRatio": 7.65,
    "currentRatio": 7.812,
    "totalRevenue": 14252000,
    "debtToEquity": 10.107,
    "revenuePerShare": 0.233,
    "returnOnAssets": -0.19633,
    "returnOnEquity": -0.36025003,
    "grossProfits": -68379000,
    "freeCashflow": -60313876,
    "operatingCashflow": -90544000,
    "revenueGrowth": -0.104,
    "grossMargins": 0.0,
    "ebitdaMargins": 0.0,
    "operatingMargins": -8.49698,
    "financialCurrency": "USD",
    "trailingPegRatio": null,
    "parent_etfs": [
        "GNOM"
    ]
}